 The results of this meta-analysis suggest that once weekly submaglutide may be more effective than once daily citagliptin in reducing HBA1C levels, SPP, DBP, body weight, waist circumference, and BMI in individuals with type 2 diabetes mellitus. Additionally, submaglutide was found to cause an increase in pulse rate, while citagliptin did not. This article was authored by Tirath Patel, Fminigita, Rohab Sohail, and others.